Change in HRQOL scores from baseline to 24 months after transplant. (A) Change in FACT-BMT total score in gilteritinib vs placebo groups across time. Clinically meaningful change is defined as a change of 10 points for FACT-BMT. (B) Change in FACT-Leu total score in gilteritinib vs placebo groups across time. Clinically meaningful change is defined as a change of 12 points for FACT-Leu. (C) Change in EQ-5D-5L VAS score in gilteritinib vs placebo groups across time. Clinically meaningful change is defined as a change of 12 points for EQ-5D-5L. SE, standard error.